Dec 21, 2021 – We now have the whole IQVIA Oncology Dynamics data asset profiled (14 countries)!
We just updated the 10 IQVIA Oncology Dynamics database profiles in our resource (China, France, Germany, Italy, Japan, Mexico, Saudi Arabia, South Korea, Spain, and UK.) In the process, we uploaded 4 new ones from Belgium, Brazil, Bulgaria, and Romania.
Dec 20, 2021 – NEW subscription rates to accommodate remote workers!
Does your company routinely use population healthcare databases? There are hundreds available and deciding on the correct one for your needs may be difficult. Subscribe to B.R.I.D.G.E.
Dec 17, 2021 – Latest profile from IBM – MarketScan® Dental Database
The IBM® MarketScan® Dental Database is a patient-level linked dental and medical insurance claims database that contains ~28.6 million covered lives. Established in 2005, this database is used for longitudinal and comparative analyses of diseases, treatment patterns, costs, duration of therapy, concomitant therapies, and other research purposes.
IQVIA Oncology Dynamics (Romania)
Email: RWDassets@iqvia.com
N/A
To find information regarding publications please visit: https://www.imsheorbibliography.com/ or contact IQVIA.
IQVIA Oncology Dynamics (Brazil)
Email: RWDassets@iqvia.com
N/A
To find information on publications please visit: https://www.imsheorbibliography.com/ or contact IQVIA for the most recent publications.
IQVIA Oncology Dynamics (Bulgaria)
Email: RWDassets@iqvia.com
N/A
To find information on publications please visit: https://www.imsheorbibliography.com/ or contact IQVIA
IQVIA Oncology Dynamics (Belgium)
Email: RWDassets@iqvia.com
N/A
Very new database; publications pending. However, you may contact IQVIA for more information.
Merative MarketScan® Dental Database (USA)
Luke Boulanger
Lead Offering Manager, MarketScan
Merative
Email: lboulang@merative.com
Email: marketscan.support@merative.com or fill out form at
https://www.merative.com/contact
1. Tranby EP, Frantsve-Hawley J, Minter-Jordan M, Thommes J, Jacob M, Monopoli M, Okunev I, Boynes SG. A cross-sectional analysis of oral health care spending over the life span in commercial- and Medicaid-insured populations. J Am Dent Assoc. 2021 Nov 9:S0002-8177(21)00486-4.
2. Chua KP, Hu HM, Waljee JF, Brummett CM, Nalliah RP. Opioid prescribing patterns by dental procedure among US publicly and privately insured patients, 2013 through 2018. J Am Dent Assoc. 2021 Apr;152(4):309-317.
3. Nasseh K, Fosse C, Vujicic M. Comparative analysis of dental procedure mix in public and private dental benefits programs. J Am Dent Assoc. 2021 Oct 1:S0002-8177(21)00482-7.
4. Chua KP, Kenney BC, Waljee JF, Brummett CM, Nalliah RP. Dental Opioid Prescriptions and Overdose Risk in Patients and Their Families. Am J Prev Med. 2021 Aug;61(2):165-173.
5. Thornhill MH, Gibson TB, Durkin MJ, Dayer MJ, Lockhart PB, O'Gara PT, Baddour LM. Prescribing of antibiotic prophylaxis to prevent infective endocarditis. J Am Dent Assoc. 2020 Nov;151(11):835-845.e31.
6. Zhou J, Calip GS, Rowan S, McGregor JC, Perez RI, Evans CT, Gellad WF, Suda KJ. Potentially Inappropriate Medication Combination with Opioids among Older Dental Patients: A Retrospective Review of Insurance Claims Data. Pharmacotherapy. 2020 Oct;40(10):992-1001.